UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
107.37
-0.01 (-0.01%)
Aug 1, 2025, 3:47 PM EDT
Splunk Market Cap
UCB SA has a market cap or net worth of $40.56 billion as of August 1, 2025. Its market cap has increased by 34.38% in one year.
Market Cap
40.56B
Enterprise Value
41.56B
Revenue
8.04B
Ranking
n/a
PE Ratio
25.93
Stock Price
$107.37
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 40.56B, an increase of 3,278.16%. That is a compound annual growth rate of 12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 40.56B | 7.44% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |